DENALI THERAPEUTICS INC (DNLI)
US24823R1059 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 48.7M -85.49% | 108.5M 122.79% | 330.531M 204.64% | 10.475M -96.83% | 54.507M 420.35% | 187.24M 243.52% | 408.6M 118.22% | 680.22M 66.48% | 880.86M 29.50% | 1.232B 39.86% | 2.033B 65.02% | |
| EBITDA YoY % growth | -287.2M -503.37% | -330.3M -15.01% | -179.973M 45.51% | -543.744M -202.13% | -533.274M 1.93% | -447.17M 16.15% | -316.04M 29.32% | -39.286M 87.57% | 374.29M 1,052.72% | 982.75M 162.56% | 1.46B 48.56% | |
| EBIT YoY % growth | -295.8M -571.77% | -340.7M -15.18% | -196.699M 42.27% | -536.823M -172.92% | -542.762M -1.11% | -454.064M 16.34% | -307.687M 32.24% | -9.074M 97.05% | 205.74M 2,367.46% | 544.12M 164.47% | 1.091B 100.51% | |
| Operating Margin | -607.39% | -314.01% | -59.51% | -5,124.80% | -995.77% | -242.50% | -75.30% | -1.33% | 23.36% | 44.17% | 53.66% | |
| EPS YoY % growth | -2.39 -1,019.23% | -2.60 -8.79% | -1.08 58.46% | -2.85 -163.64% | -2.99 -5.09% | -2.37 20.93% | -0.75 68.10% | -0.07 90.99% | 1.86 2,828.64% | 3.43 84.80% | 7.28 112.29% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.85 0.79% | -0.81 -3.26% | -0.78 -32.12% | -0.62 0.88% | -0.68 19.78% |
| Revenue Q2Q % growth | 11.305M | 5.1M | 5.1M | 35.802M | 22.389M 98.05% |
| EBITDA Q2Q % growth | -112.768M 2.66% | -125.429M 3.58% | -125.494M -11.56% | -125.551M -7.48% | -125.6M -11.38% |
| EBIT Q2Q % growth | -147.84M -11.52% | -147.433M -11.48% | -142.633M -22.33% | -108.509M 11.92% | -119.411M 19.23% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.63 12.50% | -0.63 | 0.00 | -0.50% |
| Q2 2024 Q2Q % growth | -0.59 -145.38% | -0.70 | 0.11 | 15.61% |
| Q1 2024 Q2Q % growth | -0.78 2.50% | -0.72 | -0.06 | -8.80% |
| Q4 2023 Q2Q % growth | -0.86 -14.67% | -0.82 | -0.04 | -4.84% |
| Q3 2023 Q2Q % growth | -0.72 14.29% | -0.82 | 0.10 | 12.04% |
| Q2 2023 Q2Q % growth | 1.30 370.83% | -0.70 | 2.00 | 286.35% |
| Q1 2023 Q2Q % growth | -0.80 -50.94% | -0.72 | -0.08 | -11.37% |
| Q4 2022 Q2Q % growth | -0.75 -20.97% | -0.81 | 0.06 | 6.94% |
| Q3 2022 Q2Q % growth | -0.84 -21.74% | -0.82 | -0.02 | -2.15% |
| Q2 2022 Q2Q % growth | -0.48 4.00% | -0.56 | 0.08 | 14.30% |
| Q1 2022 Q2Q % growth | -0.53 8.62% | -0.52 | -0.01 | -2.25% |
| Q4 2021 Q2Q % growth | -0.62 -132.46% | -0.42 | -0.20 | -46.88% |
| Q3 2021 Q2Q % growth | -0.69 -27.78% | -0.48 | -0.21 | -42.76% |
| Q2 2021 Q2Q % growth | -0.50 10.71% | -0.42 | -0.08 | -19.83% |
| Q1 2021 Q2Q % growth | -0.58 -5.45% | -0.35 | -0.23 | -65.09% |
| Q4 2020 Q2Q % growth | 1.91 441.07% | 0.01 | 1.90 | 23,968.75% |
| Q3 2020 Q2Q % growth | -0.54 -12.50% | 2.64 | -3.18 | -120.47% |
| Q2 2020 Q2Q % growth | -0.56 8.20% | -0.61 | 0.05 | 8.65% |
| Q1 2020 Q2Q % growth | -0.55 -34.15% | -0.58 | 0.03 | 5.40% |
| Q4 2019 Q2Q % growth | -0.56 | -0.59 | 0.03 | 4.93% |
| Q3 2019 Q2Q % growth | -0.48 | -0.57 | 0.09 | 16.41% |
| Q2 2019 Q2Q % growth | -0.61 | -0.47 | -0.14 | -29.61% |
| Q1 2019 Q2Q % growth | -0.41 | -0.41 | 0.00 | 0.34% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | 9.18M | -9.18M | -100.00% |
| Q2 2024 Q2Q % growth | -100.00% | 15.803M | -15.803M | -100.00% |
| Q1 2024 Q2Q % growth | -100.00% | 14.304M | -14.304M | -100.00% |
| Q4 2023 Q2Q % growth | -100.00% | 8.532M | -8.532M | -100.00% |
| Q3 2023 Q2Q % growth | 1.267M -64.81% | 11.404M | -10.137M | -88.89% |
| Q2 2023 Q2Q % growth | 294.123M 460.23% | 13.727M | 280.396M | 2,042.66% |
| Q1 2023 Q2Q % growth | 35.141M -16.53% | 29.294M | 5.847M | 19.96% |
| Q4 2022 Q2Q % growth | 10.3M -17.60% | 13.378M | -3.078M | -23.01% |
| Q3 2022 Q2Q % growth | 3.6M -32.08% | 14.762M | -11.162M | -75.61% |
| Q2 2022 Q2Q % growth | 52.5M 129.26% | 44.779M | 7.721M | 17.24% |
| Q1 2022 Q2Q % growth | 42.1M 432.91% | 26.206M | 15.894M | 60.65% |
| Q4 2021 Q2Q % growth | 12.5M -96.05% | 45.721M | -33.221M | -72.66% |
| Q3 2021 Q2Q % growth | 5.3M -43.62% | 30.887M | -25.587M | -82.84% |
| Q2 2021 Q2Q % growth | 22.9M 294.83% | 28.474M | -5.574M | -19.58% |
| Q1 2021 Q2Q % growth | 7.9M 119.44% | 32.256M | -24.356M | -75.51% |
| Q4 2020 Q2Q % growth | 316.8M 6,640.43% | 79.773M | 237.027M | 297.13% |
| Q3 2020 Q2Q % growth | 9.4M -30.88% | 384.98M | -375.58M | -97.56% |
| Q2 2020 Q2Q % growth | 5.8M 38.10% | 3.859M | 1.941M | 50.30% |
| Q1 2020 Q2Q % growth | 3.6M -14.29% | 5.107M | -1.507M | -29.51% |
| Q4 2019 Q2Q % growth | 4.7M | 8.791M | -4.091M | -46.54% |
| Q3 2019 Q2Q % growth | 13.6M | 9.514M | 4.086M | 42.95% |
| Q2 2019 Q2Q % growth | 4.2M | 3.999M | 201K | 5.03% |
| Q1 2019 Q2Q % growth | 4.2M | 9.301M | -5.101M | -54.84% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -18.7% | -1.53% | -10.48% |
| Revenue | 0% | -22.41% | 19.06% | -51.1% |